Table I.
Gene name | Primer sequences (5′-3′) | Product size (bp) |
---|---|---|
TLR2 | 167 | |
Sense | 5′-CAGTCCCAAAGTCTAAAGTCG-3′ | |
Antisense | 5′-TCTACGGGCAGTGGTGAAA-3′ | |
TLR4 | 151 | |
Sense | 5′-TGGGTCAAGGAACAGAAGCA-3′ | |
Antisense | 5′-TCACACTGACCACTGACACA-3′ | |
RAGE | 187 | |
Sense | 5′-CGGGACTCTTTACACTGCG-3′ | |
Antisense | 5′-CCTTCAGGCTCAACCAACA-3′ | |
NF-κB | 112 | |
Sense | 5′-GGACCTATGAGACCTTCAAGAG-3′ | |
Antisense | 5′-ACAGAAGTTGAGTTTCGGGTAG-3′ | |
AIM2 | 382 | |
Sense | 5′-CACACTCGACGTGGCAGATAGGAC-3′ | |
Antisense | 5′-CAGCACCGTGACAACAAGTGG-3′ | |
ASC | 121 | |
Sense | 5′-CACCAGCCAAGACAAGATGA-3′ | |
Antisense | 5′-CTCCAGGTCCATCACCAAGT-3′ | |
Caspase-1 | 190 | |
Sense | 5′-AACAGAACAAAGAAGATGGCACA-3′ | |
Antisense | 5′-CCAACCCTCGGAGAAAGAT-3′ | |
GAPDH | 150 | |
Sense | 5′-TGTGTCCGTCGTGGATCTGA-3′ | |
Antisense | 5′-TTGCTGTTGAAGTCGCAGGAG-3′ |
TLR, Toll-like receptor; RAGE, receptor for advanced glycation end products; NF, nuclear factor; ASC, apoptosis-associated speck-like protein containing a CARD.